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0929-6646/Copyright ª 2014, ElsevierQuality measurement is important to stakeholders in providing valid information for improve-
ment, and has been associated with hospital accreditation in most countries. The commonly
used categories of indicators are structure, process, and outcome. Outcome indicators are
of foremost importance as they reflect the effect of health care; structure indicators are
commonly used for assessing capacities or facilities available for providing services, whereas
process indicators assess how well the service is delivered, and provide essential and important
information for quality improvement. For a process indicator to be valid, it should be linked to
an outcome, whereas a structure indicator must be linked to a better outcome. Although there
are no strict rules for usage or selection of indicators, it is important to ensure adequate
coverage of relevant domains of the health care services intended to be evaluated. Because
the trends in health care services and management are changing, it is time to have a paradigm
shift in health care quality measurement. Although evaluating the quality had also been
extended to include quality of life and patient satisfaction, the ultimate aim of health care
services should be “staying healthy, getting healthy, and living healthy”. It is important for
physicians to learn how to use these clinical indicators for improving service performance
and organizational growth.
Copyright ª 2014, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
It has been said, “No measurement, no management.”1
Comprehensive and well-designed data management is




Taiwan LLC & Formosan Medicalregulatory officers in providing trustworthy information for
quality improvement.2e4 In the United States, the Joint
Commission (JC) began its development of performance
measurements in 19865; later on, the JC initiated a so-
called Hospital Core Measure Pilot Project inant to this article.
Taiwan University Hospital, Number 7, Zhongshan South Road,
Association. All rights reserved.
Figure 1 Road map for selection of indicators based on
factors that might contribute to different domains of mea-
surement for the quality of health care during the whole pro-
cess of service.




Structure Number of board-certified physicians
Nurse/bed ratio
Percentage of full-time attending physicians
Average year of experience at work for staff
Process Average hospital days for inpatients
Surgical operation numbers
Bed-occupation rate for inpatient service
Rate of thrombolytic therapy for acute
ischemic stroke patients
Rate of coronary intervention for acute
myocardial infarction
Adequate timing for prophylactic antibiotics
before surgery
Rate of admission via emergency department
Completion rate of discharge summary
Outcome Mortality rate for all inpatients
Mortality rate for the intensive care
unit patients
Surgical mortality
Readmission within 14 d after discharge for
inpatients
Return to the intensive care unit within 48 h




Adverse drug reaction numbers
Satisfaction of the patients
674 K.-Y. Hung, J.-S. Jerng1999e2001.6,7 The project aimed to develop, for major
diseases or modes of service, a set of indicators, which
when evaluated together can provide a robust assessment
of the quality of care in a specialized area of health care
facilities.8e10
In Taiwan, accreditation for teaching hospitals was
started in accordance with the guidelines recommended by
the Department of Health (DOH) and the Ministry of Edu-
cation in 1978,11 and since 1988 all hospitals were required
to be accredited by the DOH. In 1999, the Taiwan Joint
Commission on Hospital Accreditation (TJCHA), founded by
the DOH, was established to take responsibility for hospital
accreditations.11,12 The TJCHA also aimed to promote
patient-safety culture and quality management, and
therefore, the TJCHA launched the Taiwan Quality Indica-
tor Project system13 to benchmark and assess health care
performance among various hospitals in Taiwan.13,14
Because improvements are data driven, and modern
medicine is a growing complex and could be delivered by
cross-departmental teams, institutional leaders require
quality indicators to measure a team’s perform-
ance.2,3,7,14e16 The objective of this paper is to provide a
brief review of categories and characteristics of clinical
indicators for measuring quality in health care systems.
Because the Taiwanese health care system accelerated its
reform under the current insurance policies14 or to match
trends worldwide,8,10,16 in the second part of this article we
will describe the focus shifting of these indicators in order
to cope with future needs. In this work, we would like to
show you why it is time to have a paradigm shift in health
care quality measurement.
Category of quality indicators
In order to document or compare how health care services
are delivered among individual hospitals, it is necessary to
implement or develop different categories of quality in-
dicators.2,3 Through these indicators, we may have a more
comprehensive view of how these health care services were
provided, what kinds of resources and procedures were
allocated, and the relationships linking hospital perfor-
mance to patients or outcome of diseases.2,4,17e19 The
commonly used categories for classification of performance
indicators are structure, process, and outcome.2,20e22 A
simple demonstration of the road map for choosing
different domains of quality indicators is depicted in Fig. 1.
Different types of indicators can be used either indepen-
dently or in combination as a bundle for special situations
to objectively measure staff performance or outcome for a
given purpose. Examples of different types of indicators are
shown in Table 1.
Structure
Structure indicators are most commonly used for assessing
capacities or facilities available for providing a given type
of health care service.14,22 In hospital accreditations,
these indicators usually mean whether the specific
accredited hospital has the necessary equipment, program,
technology, supplies, or staff to deliver related
services.14,17,18,23,24Structure indicators seem to be more appealing, as they
are clearly defined and easy to collect or evaluate; in
addition, surveys/questionnaires to evaluate structure in-
dicators are usually in a yes/no pattern.
Process
Unlike structure indicators, process indicators are used for
assessing how well a given health care service was
Paradigm shift in quality measurement 675delivered. It provides essential and important information
for quality improvement.14,23,24 However, the most time-
consuming and difficult area during quality measurement
is that not all actions of the process are written down or
recorded. Some information about certain health care
services relies on simultaneous observations or needs
manual abstraction retrospectively.25e27 For example, to
reduce drug-dispensing error at an outpatient pharmacy,
we need to check the related processes prior to and during
drug dispensing to patients.28,29 In addition, we also need
to review the drug-dispensing scene at the pharmacy, in
combination with an on-site interview with staff, or even
using live recordings. For instance, to improve the perfor-
mance of an in-hospital rapid response team, we might use
these management tools for data collection.30e32
Because of the increasingly popular methods used for
electronic collection of medical records in Taiwan and in
various countries worldwide, it is now much easier to
measure in advance what is actually done at a health care
service, by transforming activities carried out for data
collection into a set of process indicators.16,26,27
Outcome
Outcome indicators are given primary importance, as they
reflect the effect of health care or therapy.33 Outcome
indicators also reflect the validity of process defined, or the
adequacy of structure designed.34 For a process indicator to
be valid, it should be linked to an outcome effect. For a
structure indicator to be adequately defined, it must be
linked to a better outcome.20 The most commonly used
outcome indicators are mortality and morbidities. Howev-
er, multiple factors may also contribute to patient outcome
as well as the results or effectiveness of a certain ther-
apy.35,36 Therefore, before comparing outcome indicators
across different hospitals or health care institutes, we need
to control potential confounding factors using risk adjust-
ment or other suitable statistical methods.33,37,38
Recently, the definitions of outcome had been extended
to include quality of life (QOL)39e42 and patient
satisfaction.43,44
Usage of quality indicators
There are no general rules about the usage or selections of
indicators. The most important point is to ensure adequate
coverage of relevant domains of the health care services
that you intend to evaluate.45,46 A simplified and reason-
able approach is to divide further the purpose of mea-
surement into three dimensions. First, we should assess the
“outcome” of the service, that is, what is the effect and
impact of the service? Second, we might want to know how
the services were provided. That is what “process in-
dicators” are for. Third, whether we are concerned about
the sustainability of a similar performance for other or
future patients? We can then assess what resources were
used for the related service and whether they fit into the
characteristics of “structure indicators”.
Regardless ofwhat indicatorswere selectedor chosen, the
feasibility andvalidity of indicators are themost fundamental
and essential components.15,26,27 Besides, indicator validityand reliability are two crucial aspects of clinical measure-
ment.47 Sometimes we should also consider the frequency
and reporting burden. We should better know in advance
whether the cost of data collection and reporting outweigh
the value of the measurement for obtaining information.
Example 1: Quality indicators for thrombolytic
therapy in acute ischemic stroke
To improve the quality of care and outcome of patient with
acute ischemic stroke presenting at the emergency
department, the multidisciplinary team for treatment of
acute stroke at the National Taiwan University Hospital,
Taipei, Taiwan established a stroke protocol based on the
Taiwan Guidelines for the Management of Acute Stroke
2008, proposed by the Taiwan Stroke Society.48,49 For
evaluating staff performance and for continued quality
improvement, we use quality indicators for measuring this
critical service. We selected indicators for screening,
diagnosis, treatment, and follow-up implementation of this
guideline. Table 2 illustrates the categories of indicators
and rationale of indicators chosen for measuring acute
stroke thrombolytic therapy service. Through a series of
improvement actions, we established processeoutcome
indicators for this implementation. We also found that
process indicators are especially useful if improvement is
the goal and an explanation is sought as to why the ex-
pected outcomes could or could not be achieved.
Example 2: Care for pediatric patients with newly
diagnosed asthma
Quality assessment of asthma care for evaluating staff
performance had been tested elsewhere.50 To improve
service of asthma care in pediatric patients, we imple-
mented the Global Initiative for Asthma guidelines for the
management of chronic asthma in children. Again, we
selected indicators for screening, diagnosis, treatment, and
follow-up implementation of this guideline. Table 3 illus-
trates the categories of indicators and rationale of in-
dicators chosen for pediatric asthma patients.
To summarize our recommendations on the selection and
usage of indicators, there are three points. First, outcome
indicators may be sufficient for measuring total effect, but
they shouldbe linkedtoprocess indicators,whichcan identify
improvement areas in order to make the delivery of health
care services better. Second, revised or redesigned organi-
zational structure or processes nearly always promise better
outcomes. The relationship between structur-
eeprocesseoutcome should be evidence based, and needs to
be demonstrated through continued actions on quality
improvement for sustainability. The thirdand thefinal point is
to rethink the cost and effectiveness of such ameasurement.
Paradigm shift of quality indicators in health
care
The future of health care services and their management is
changing.16 Over the past decades, the health care services
had witnessed a vast variety of quality improvement
Table 2 Examples of quality indicators for measuring acute stroke thrombolytic therapy service.
Name of the indicator Indicator type Definition
Stroke screening tool use Structure Validated tool used to screen for stroke by ambulance staff
in patients with neurological symptoms.
Brain CT within 25 min after arrival Process Numerator: Number of patients with brain CT performed within
25 min after arrival at ER.
Denominator: Number of patients with stroke who arrive at ER
within 3 h of symptom onset.
Rate of door-to-needle time <60 min Process Numerator: Number of ischemic stroke patients who receive
thrombolytic therapy within 60 min after arrival at ER.
Denominator: Number of patients with ischemic stroke who
receive thrombolytic therapy.
Rate of thrombolytic therapy of
ischemic stroke patients
Process Numerator: Number of patients who receive thrombolytic therapy.
Denominator: Number of ischemic stroke patients who come to
the hospital within 10 d of symptom onset.
Symptomatic intracranial hemorrhage
after thrombolytic therapy
Outcome Numerator: Number of patients who developed intracranial
hemorrhage with increase of NIHSS score for more than 2 points
within 36 h after thrombolytic therapy.
Denominator: Number of ischemic stroke patients who receive
thrombolytic therapy.
Rate of minimal sequelae after
thrombolytic therapy
Outcome Numerator: Number of patients with Modified Rankin Scale 0e1
3 mo after thrombolytic therapy.
Denominator: Number of ischemic stroke patients who receive
thrombolytic therapy.
CT Z computed tomography; ER Z emergency room; NIHSS Z National Institutes of Health Stroke Scale.
676 K.-Y. Hung, J.-S. Jerngactivities. In a number of instances, there are some nov-
elties that contribute to changes in fundamental viewpoints
in the health care system. For example, the advocating for
patient safety was one of the changes that significantlyTable 3 Examples of quality indicators for caring for pediatric
Name of indicator Indicator type Defini



























Rate of visit to the ER Outcome Nume
bro
Denom
ER Z emergency room.altered our view on patient management.51,52 Another
evolutionary change is to apply the management of quality
indicators in evaluating the efficiency of a patient-centered
care.53,54 In addition, the widespread use of informationasthma patients.
tion
ce of dedicated nurses trained for education and
nitoring of patients referred for asthma care.
rator: Number of patients with documentation of asthma
trol status in the electronic medical records.
inator: Number of newly included patients with
nchial asthma.
rator: Number of patients with documentation of breathing
nds in the electronic medical records.
inator: Number of newly included patients with
nchial asthma.
rator: Number of patients with documentation of education
asthma care in the electronic medical records.
inator: Number of newly included patients with
nchial asthma.
rator: Number of patients who return to the appointed
ic within 3 mo.
inator: Number of included patients with bronchial asthma.
rator: Number of patients with Asthma Control Test
re >20 upon the first follow-up visit.
inator: Number of newly included patients with
nchial asthma.
rator: Number of visits to the ER due to exacerbation of
nchial asthma.
inator: Number of all included patients.
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has also significantly contributed to changing the shape of
the health care practice.55,56 These changes and new ap-
plications might contribute to the so-called paradigm shift
in the health care philosophy and system,57 which essen-
tially depicted a revolution that “one conceptual world
view is replaced by another”.57
To cope with the rapid emergence of new models of
clinical services, it is time to consider a paradigm shift in
quality measurement of health care services. For example,
patients or payers may need to know how to measure or
make comparison across medical cosmetology centers, or
to evaluate the cost and efficiency of robotic surgery (the
da Vinci Surgical System). Both fields have become popular
worldwide in the recent decade. The ultimate aim of a
health care service should be staying healthy, getting
healthy, and living healthy. Therefore, the interest and
focus of payers and policy makers are likely to have a
paradigm shift from disease therapy to disease prevention,
or further to health promotion. In addition to these fields or
new applications, other new dimensions, such as patient
satisfaction,43,44,58 patient experience data,59e63 or QOL,
are attracting more attention of epidemiologists and health
care service providers. Recently, an analysis of outcomes
reported in high-impact surgical journals demonstrated the
emerging needs.64 Of the 770 articles analyzed in the
report, only 36% had reports for symptom outcomes, 13.4%
for functional status outcomes, 10.6% for general health
status outcome, and 14.8% for overall QOL as outcomes.
These were in contrast to the 91.6% reporting for biological
and physiological outcomes, which underscored the need
for the applicability of the measures.64 From the quality
point of view, these findings might also suggest an emerging
need for a paradigm shift toward patient-centered mea-
surements. The advocating for patient-reported outcomes
by the U.S. Food and Drug Administration65 and a recent
report from the Consolidated Standards of Reporting Tri-
als66 also provide an example of current thinking. The
traditional concept about structure, process, or outcome
indicators may need to be revised and extended further
with regard to the current thinking.Conclusion
Data on clinical indicators are of interest to clinicians,
organizational providers, and patients as they can be used
to achieve improvements in health care and to understand
areas that can be improved. In general, outcome data are
of the greatest benefit as they directly reflect the effec-
tiveness of diagnostic or therapeutic actions. However, the
health care providers need more detailed information to
understand how the health care services are delivered. It
can be accomplished by applying process and structure in-
dicators for measurement.
To fit real patient perceptions, a new category of quality
indicators are evolving, such as the indicators for patient
satisfaction, QOL, or those for measuring huge amounts of
data in the field of public health issues or for the interest of
epidemiologists. It is important that physicians learn to use
these clinical indicators for self-improvement in service
performance and for organizational growth.References
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